4.5389
price down icon3.43%   -0.1211
 
loading
Schlusskurs vom Vortag:
$4.66
Offen:
$4.66
24-Stunden-Volumen:
129.90K
Relative Volume:
0.07
Marktkapitalisierung:
$780.00M
Einnahmen:
$25.55M
Nettoeinkommen (Verlust:
$-341.97M
KGV:
-1.6873
EPS:
-2.69
Netto-Cashflow:
$-304.44M
1W Leistung:
-19.64%
1M Leistung:
-30.02%
6M Leistung:
-40.48%
1J Leistung:
-43.47%
1-Tages-Spanne:
Value
$4.48
$4.715
1-Wochen-Bereich:
Value
$4.48
$5.63
52-Wochen-Spanne:
Value
$4.48
$12.14

Relay Therapeutics Inc Stock (RLAY) Company Profile

Name
Firmenname
Relay Therapeutics Inc
Name
Telefon
617-370-8837
Name
Adresse
399 BINNEY STREET, CAMBRIDGE
Name
Mitarbeiter
294
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-06
Name
Neueste SEC-Einreichungen
Name
RLAY's Discussions on Twitter

Vergleichen Sie RLAY mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
RLAY 4.54 780.00M 25.55M -341.97M -304.44M -2.69
VRTX 446.82 115.74B 10.63B -479.80M -1.35B 13.33
REGN 738.18 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 585.10 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 248.38 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 102.30 24.49B 3.30B -501.07M 1.03B 11.54

Relay Therapeutics Inc Stock (RLAY) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-04-20 Hochstufung Jefferies Underperform → Hold
2023-04-19 Hochstufung Raymond James Outperform → Strong Buy
2023-04-13 Eingeleitet Raymond James Outperform
2023-02-03 Eingeleitet Oppenheimer Outperform
2022-09-30 Eingeleitet Barclays Equal Weight
2022-09-02 Eingeleitet Stifel Buy
2022-06-06 Eingeleitet Jefferies Underperform
2022-02-01 Eingeleitet Berenberg Buy
2021-07-21 Eingeleitet BofA Securities Buy
2020-12-15 Bestätigt H.C. Wainwright Buy
2020-12-08 Eingeleitet JMP Securities Mkt Outperform
2020-11-05 Eingeleitet H.C. Wainwright Buy
2020-08-10 Eingeleitet Cowen Outperform
2020-08-10 Eingeleitet Goldman Buy
2020-08-10 Eingeleitet Guggenheim Buy
2020-08-10 Eingeleitet JP Morgan Neutral
Alle ansehen

Relay Therapeutics Inc Aktie (RLAY) Neueste Nachrichten

pulisher
Nov 20, 2024

Down -27.93% in 4 Weeks, Here's Why Relay Therapeutics (RLAY) Looks Ripe for a Turnaround - Yahoo Finance

Nov 20, 2024
pulisher
Nov 19, 2024

Down -23.95% in 4 Weeks, Here's Why Relay Therapeutics (RLAY) Looks Ripe for a Turnaround - Yahoo Finance

Nov 19, 2024
pulisher
Nov 19, 2024

First Turn Management LLC Buys New Holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY) - MarketBeat

Nov 19, 2024
pulisher
Nov 18, 2024

Layoff Tracker: Adaptimmune Downsizes by 33% in Strategic Realignment - BioSpace

Nov 18, 2024
pulisher
Nov 17, 2024

Relay Therapeutics (NASDAQ:RLAY) Trading Down 4.8% – Here’s What Happened - Defense World

Nov 17, 2024
pulisher
Nov 15, 2024

Relay Therapeutics (NASDAQ:RLAY) Stock Price Down 4.8%Time to Sell? - MarketBeat

Nov 15, 2024
pulisher
Nov 14, 2024

(RLAY) Trading Report - Stock Traders Daily

Nov 14, 2024
pulisher
Nov 14, 2024

Relay Therapeutics stock hits 52-week low at $5.59 - Investing.com India

Nov 14, 2024
pulisher
Nov 14, 2024

Relay Therapeutics stock hits 52-week low at $5.59 By Investing.com - Investing.com UK

Nov 14, 2024
pulisher
Nov 14, 2024

Analyzing Valneva (NASDAQ:VALN) and Relay Therapeutics (NASDAQ:RLAY) - Defense World

Nov 14, 2024
pulisher
Nov 14, 2024

NKGen Biotech (NYSE:NKGN) versus Relay Therapeutics (NASDAQ:RLAY) Financial Contrast - Defense World

Nov 14, 2024
pulisher
Nov 13, 2024

Relay Therapeutics' SWOT analysis: PI3K inhibitor progress fuels stock potential - Investing.com

Nov 13, 2024
pulisher
Nov 12, 2024

HC Wainwright Forecasts Strong Price Appreciation for Relay Therapeutics (NASDAQ:RLAY) Stock - Defense World

Nov 12, 2024
pulisher
Nov 11, 2024

Research Analysts Offer Predictions for RLAY FY2024 Earnings - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

FY2024 Earnings Estimate for RLAY Issued By Leerink Partnrs - Defense World

Nov 11, 2024
pulisher
Nov 09, 2024

Relay Therapeutics (NASDAQ:RLAY) Given New $20.00 Price Target at HC Wainwright - MarketBeat

Nov 09, 2024
pulisher
Nov 07, 2024

Relay Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times

Nov 07, 2024
pulisher
Nov 07, 2024

RLAYRelay Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Nov 07, 2024
pulisher
Nov 07, 2024

Relay Therapeutics Reports Q3 2024 Results and Advances - TipRanks

Nov 07, 2024
pulisher
Nov 06, 2024

Relay Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Highlights - The Manila Times

Nov 06, 2024
pulisher
Nov 06, 2024

Relay Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 06, 2024
pulisher
Nov 04, 2024

Where are the Opportunities in (RLAY) - Stock Traders Daily

Nov 04, 2024
pulisher
Oct 31, 2024

Relay Therapeutics (RLAY) to Release Earnings on Wednesday - MarketBeat

Oct 31, 2024
pulisher
Oct 31, 2024

Relay Therapeutics stock hits 52-week low at $5.7 amid market shifts - Investing.com Australia

Oct 31, 2024
pulisher
Oct 30, 2024

Relay Therapeutics stock hits 52-week low at $5.7 amid market shifts By Investing.com - Investing.com South Africa

Oct 30, 2024
pulisher
Oct 30, 2024

Relay Therapeutics to Announce Third Quarter 2024 Financial Results and Corporate Highlights on November 6, 2024 - The Manila Times

Oct 30, 2024
pulisher
Oct 30, 2024

Relay Therapeutics to Announce Third Quarter 2024 Financial Results and Corporate Highlights on November 6, - EIN News

Oct 30, 2024
pulisher
Oct 29, 2024

Intrahepatic Cholangiocarcinoma Pipeline Update 2024: FDA Approvals, Therapeutic Advancements, and Key Companies involved by DelveInsight | Xencor, Relay Therapeutics, Kinnate Biopharma, Forma Therapy - Barchart

Oct 29, 2024
pulisher
Oct 28, 2024

Institutional owners may consider drastic measures as Relay Therapeutics, Inc.'s (NASDAQ:RLAY) recent US$67m drop adds to long-term losses - Yahoo Finance

Oct 28, 2024
pulisher
Oct 28, 2024

Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Oct 28, 2024
pulisher
Oct 25, 2024

Several Relay Therapeutics Insiders Sell Shares Sending Potential Negative Signal - Simply Wall St

Oct 25, 2024
pulisher
Oct 25, 2024

Relay Therapeutics' SWOT analysis: oncology innovator's stock faces pivotal phase - Investing.com Canada

Oct 25, 2024
pulisher
Oct 24, 2024

Relay Therapeutics' SWOT analysis: oncology innovator's stock faces pivotal phase By Investing.com - Investing.com South Africa

Oct 24, 2024
pulisher
Oct 16, 2024

Financial Snapshot: Analyzing Relay Therapeutics Inc (RLAY)’s Key Ratio Metrics - The Dwinnex

Oct 16, 2024
pulisher
Oct 15, 2024

Relay Therapeutics, Inc. (NASDAQ:RLAY) Short Interest Update - MarketBeat

Oct 15, 2024
pulisher
Oct 14, 2024

How did Relay Therapeutics Inc (RLAY) fare last session? - US Post News

Oct 14, 2024
pulisher
Oct 14, 2024

Relay Therapeutics (NASDAQ:RLAY) Receives Buy Rating from HC Wainwright - MarketBeat

Oct 14, 2024
pulisher
Oct 14, 2024

Relay Therapeutics stock holds price target on FDA approval By Investing.com - Investing.com UK

Oct 14, 2024
pulisher
Oct 14, 2024

Relay Therapeutics Inc (RLAY) receives a Buy rating from Jefferies - Knox Daily

Oct 14, 2024

Finanzdaten der Relay Therapeutics Inc-Aktie (RLAY)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Relay Therapeutics Inc-Aktie (RLAY) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Catinazzo Thomas
Chief Financial Officer
Oct 28 '24
Sale
6.06
6,802
41,220
306,391
Catinazzo Thomas
Chief Financial Officer
Oct 29 '24
Sale
5.95
2,300
13,685
304,091
Bergstrom Donald A
President, R&D
Oct 28 '24
Sale
6.06
2,688
16,289
520,745
Adams Brian
Chief Legal Officer
Oct 28 '24
Sale
6.06
1,632
9,890
321,907
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Kapitalisierung:     |  Volumen (24h):